Home
About
Publications Trends
Recent Publications
Expert Search
Archive
novel compounds
What are Some Examples of Novel Compounds in Cancer Research?
Several novel compounds have shown promise in cancer research. For instance,
immunomodulatory drugs
like
lenalidomide
and
pomalidomide
are being used to treat multiple myeloma.
PARP inhibitors
such as
olaparib
have been effective in treating BRCA-mutated ovarian and breast cancers. Other innovative compounds include
KRAS inhibitors
and
checkpoint inhibitors
.
Frequently asked queries:
What are Novel Compounds?
How are Novel Compounds Discovered?
What are Some Examples of Novel Compounds in Cancer Research?
What Challenges Do Novel Compounds Face?
How Do Novel Compounds Enhance Existing Treatments?
What is the Future of Novel Compounds in Cancer Treatment?
When is Cancer Surgery Used?
What Future Directions are Promising?
How are Metastatic Brain Tumors Diagnosed?
How Does the Type of Cancer Affect Diagnosis?
What are Cancer Repositories and Databases?
Why is hypomagnesemia a concern in cancer patients?
How should fresh fruits be incorporated into the diet for optimal benefits?
What are PD-1 Inhibitors?
What Are the Limitations of FMLA?
How Can Patients Overcome Emotional Barriers?
Why is Personal Connection Important in Cancer Care?
What are Uniform Guidelines in Cancer Care?
How Can Scooters Help with Mobility?
What Happens if a Patient Misses the Open Enrollment Period?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe